Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C
94%
Apolipoprotein A
94%
Autoantibody
63%
Atherosclerosis
47%
Antiviral Therapy
40%
Chronic Hepatitis C
40%
Liver Disease
36%
Lipoprotein
34%
Bacteriophage
31%
Bronchiectasis
31%
Proprotein Convertase 9
31%
Poxviridae
31%
Apolipoprotein E
31%
Vaccinia virus
31%
DNA Immunization
31%
Virus Envelope Protein
31%
Boceprevir
31%
Telaprevir
31%
Disease Exacerbation
31%
Dipeptidyl Peptidase IV
31%
Hepatitis C Vaccine
31%
Flavivirus
31%
Hepatitis C Virus
27%
Low Density Lipoprotein Cholesterol
18%
Triacylglycerol
15%
Dyslipidemia
15%
Persistent Infection
15%
Maturity Onset Diabetes of the Young
15%
SARS Coronavirus
14%
Coronavirinae
14%
Low Density Lipoprotein Receptor
13%
Cardiovascular Disease
13%
Apolipoprotein B
13%
Liver Cirrhosis
12%
Virus RNA
12%
Fibronectin
12%
Interferon
10%
Immunology and Microbiology
Hepatitis C
100%
Hepatitis C Virus
73%
Atherosclerosis
73%
Autoantibodies
68%
Apolipoprotein
63%
Infection
38%
Lipoprotein Metabolism
31%
Apolipoprotein E
31%
Low-Density Lipoprotein
31%
Bacteriophage
31%
Host Range
31%
Pseudomonas aeruginosa
31%
Antibiotic Sensitivity
31%
Lipid Liver Level
31%
Macaca fascicularis
31%
Bacterial Metabolism
31%
NOD2
31%
Hepatitis C Vaccine
31%
Flavivirus
31%
Hepatitis C Virus Genotype 1
31%
Insulin Resistance
21%
CD81
21%
High-Density Lipoprotein
18%
Apolipoprotein B
17%
Virotherapy
15%
Pegylated Interferon
12%
Interferon-Stimulated Gene
12%
Macaca
12%
DNA Immunization
12%
Fibronectin
12%
Triglyceride-Rich Lipoprotein
11%
Cholesterol Blood Level
10%
Proteoglycan
10%
Virus Particle
10%
Pretreatment
10%
Lipid Metabolism
10%
Immune Escape
10%
Biochemistry, Genetics and Molecular Biology
Hepatitis C Virus
67%
Apolipoprotein
63%
Autoantibody
63%
Lipoprotein Metabolism
31%
Kexin
31%
Apolipoprotein E
31%
Subtilisin
31%
Proprotein Convertase
31%
Flavivirus
31%
Hepatitis C Virus Genotype 1
31%
Apolipoprotein B
15%
LDL Receptor
13%
Fibronectin
12%
Virus Load
11%